跳至主要内容
临床试验/ISRCTN89080534
ISRCTN89080534已完成不适用

The use of erythropoietin in cardiac surgery to protect against ischaemia-related injury in kidney and other organ systems

HS Greater Glasgow and Clyde (UK)0 个研究点目标入组 84 人开始时间: 2006年6月2日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. First-time coronary artery bypass surgery
  • 2. Age >70
  • 3. Serum creatinine >120 µmol/l
  • 4. Diabetes mellitus (diet or medication controlled)

排除标准

  • 1. Hypersensitiviy to mammalian cell-derived products to (human) albumin, to EPO or any of the ingredients of EPO
  • 2. Hypercoagulability
  • 3. Significant psychiatric or neurological disease that would prevent adherence to the requirements of the protocol
  • 4. Immunosuppression immunocompromised (including, but not limited to aquired immune deficiency syndrome (AIDS) and immunosuppressive therapy)
  • 5. Significant hepatic disturbance
  • 6. Chronic renal impairment (requiring haemodialysis or peritoneal dialysis)
  • 7. Pregnant or breast feeding
  • 8. Current treatment with human recombitant erythropoietin
  • 9. Previous cardiac surgery

研究者

发起方
HS Greater Glasgow and Clyde (UK)

相似试验